Onesource Specialty Pharma Ltd

💉 Tentative FDA Approval for Generic Ozempic® via OneSource & Orbicular Partnership

- Tentative FDA approval received for generic version of Ozempic® (Semaglutide Injection)

- OneSource served as CDMO partner, providing end-to-end manufacturing support for U.S. market filing

- Manufacturing leveraged OneSource’s US-FDA approved site in Bangalore

- Collaboration aims to ensure reliable commercial supply of the generic product

- Strengthens OneSource’s position as a global CDMO for drug-device combinations and complex injectables